LeMaitre Vascular Inc (LMAT) Stock Price, Trades & News

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Financial Strength

8/10

Name	Current	Vs Industry
Cash-To-Debt	1.98
Equity-to-Asset	0.66
Debt-to-Equity	0.45
Debt-to-EBITDA	1.89
Interest Coverage	14.88
Piotroski F-Score	6/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	7.21	Distress Grey Safe
Beneish M-Score	-2.76	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

10/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	14.3
	3-Year EBITDA Growth Rate	33.5
	3-Year EPS without NRI Growth Rate	26.2
	3-Year FCF Growth Rate	48.1
	3-Year Book Growth Rate	12.5
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	10.62
	Future 3-5Y Total Revenue Growth Rate Estimate	9.48

Momentum Rank

8/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	46.47
	9-Day RSI	40.63
	14-Day RSI	38.96
	3-1 Month Momentum %	13.06
	6-1 Month Momentum %	-0.59
	12-1 Month Momentum %	8.97

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	16.31
	Quick Ratio	14.38
	Cash Ratio	12.57
	Days Inventory	297.99
	Days Sales Outstanding	48.41
	Days Payable	19.95

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	1.18
	Dividend Payout Ratio	0.35
	3-Year Dividend Growth Rate	17
	Forward Dividend Yield %	1.24
	5-Year Yield-on-Cost %	2.39
	3-Year Average Share Buyback Ratio	-1
	Shareholder Yield %	-1.21

Profitability Rank

10/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	72.9
	Operating Margin %	29.46
	Net Margin %	25.03
	EBITDA Margin %	38.27
	FCF Margin %	28.13
	OCF Margin %	31.62
	ROE %	16.74
	ROA %	10.73
	ROIC %	26.07
	3-Year ROIIC %	159.57
	ROC (Joel Greenblatt) %	71.58
	ROCE %	15.52
	Years of Profitability over Past 10-Year	10
	Moat Score	5
	Tariff Resilience Score	6

GF Value Rank

10/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	28.31
	Forward PE Ratio	25.38
	PE Ratio without NRI	30.97
	Shiller PE Ratio	51.37
	Price-to-Owner-Earnings	31.31
	PEG Ratio	2.01
	PS Ratio	7.29
	PB Ratio	4.39
	Price-to-Tangible-Book	5.7
	Price-to-Free-Cash-Flow	25.96
	Price-to-Operating-Cash-Flow	23.1
	EV-to-EBIT	18.45
	EV-to-EBITDA	16.52
	EV-to-Forward-EBITDA	28.45
	EV-to-Revenue	6.32
	EV-to-Forward-Revenue	5.41
	EV-to-FCF	22.47
	Price-to-GF-Value	0.84
	Price-to-Projected-FCF	2.12
	Price-to-DCF (Earnings Based)	1.46
	Price-to-DCF (FCF Based)	1.16
	Price-to-Median-PS-Value	1.06
	Price-to-Peter-Lynch-Fair-Value	1.89
	Price-to-Graham-Number	2.8
	Price-to-Net-Current-Asset-Value	6.88
	Price-to-Net-Cash	11.83
	Earnings Yield (Greenblatt) %	5.42
	FCF Yield %	4
	Forward Rate of Return (Yacktman) %	18.64

Financials (Next Earnings Date:2026-11-06 Est.)

Annual Quarterly TTM

LMAT's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Gurus Latest Trades with NAS:LMAT

No Available Data

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

LeMaitre Vascular Inc Executives

Details

GF Value™: $95.52

LMAT

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 10 Good signs with LMAT. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil $)	262.432
	EPS (TTM) ($)	2.85
	Beta	0.7476
	3-Year Sharpe Ratio	0.35
	3-Year Sortino Ratio	0.61
	Volatility %	40.33
	14-Day RSI	38.96
	14-Day ATR ($)	2.794529
	20-Day SMA ($)	81.27275
	12-1 Month Momentum %	8.97
	52-Week Range ($)	78.27 - 118.01
	Shares Outstanding (Mil)	22.87

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	6
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

LeMaitre Vascular Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

LeMaitre Vascular Inc Stock Events

Financials Calendars

Event	Date	Price ($)
Annual report for 2026	2027-02-26	In 172 days
Fourth quarter earnings conference call for 2026	2027-02-25 17:00	In 172 days
Fourth quarter earnings results for 2026	2027-02-25	In 171 days
Third quarter earnings conference call for 2026	2026-11-06 17:00	In 61 days
Third quarter earnings results for 2026	2026-11-06	In 60 days
19(th) Annual Barrington Research Virtual Fall Investment Conference	2026-09-22	In 15 days
Morgan Stanley 24(th) Annual Global Healthcare Conference	2026-09-16 12:20	In 10 days
Wells Fargo 21(st) Annual Healthcare Conference	2026-09-08 08:45	In 2 days
USD 0.250000 Cash Dividend	2026-08-20	83.87 (+2.82%)
Second quarter earnings conference call for 2026	2026-08-04 17:00	103.61 (+0.41%)

Show

Entries

LeMaitre Vascular Inc Frequently Asked Questions

What is LeMaitre Vascular Inc(LMAT)'s stock price today?

The current price of LMAT is $80.68. The 52 week high of LMAT is $118.01 and 52 week low is $78.27.

When is next earnings date of LeMaitre Vascular Inc(LMAT)?

The next earnings date of LeMaitre Vascular Inc(LMAT) is 2026-11-06 Est..

Does LeMaitre Vascular Inc(LMAT) pay dividends? If so, how much?

The Dividend Yield % of LeMaitre Vascular Inc(LMAT) is 1.18% (As of Today), Highest Dividend Payout Ratio of LeMaitre Vascular Inc(LMAT) was 0.48. The lowest was 0.25. And the median was 0.37. The Forward Dividend Yield % of LeMaitre Vascular Inc(LMAT) is 1.24%. For more information regarding to dividend, please check our Dividend Page.

Guru Commentaries on NAS:LMAT

Conestoga Micro Cap Composite Bearish

2026 Q2

What the manager wrote

LeMaitre Vascular, Inc. (LMAT) was the weakest performer in our portfolio, accounting for more than half of our total sector losses. Despite delivering a strong fundamental quarter with 10% organic revenue growth and gross margins of 72.1%, the shares declined following the earnings release as investors took profits in one of the medical device sector's strongest performers. We continue to believe the company is well positioned to generate attractive revenue and earnings growth over the coming years, supported by its differentiated vascular product portfolio and consistent execution.

Riverwater Partners Small Cap Strategy Bullish

2026 Q2

What the manager wrote

LeMaitre Vascular, our peripheral vascular device holding, declined approximately 12% in a quarter when nearly everything profitable in small cap health care went down and nearly everything speculative went up. The company's niche leadership, pricing power, and consistent execution are unchanged, and we view the weakness as sentiment-driven rather than fundamental.

Conestoga Micro Cap Composite Bullish

2026 Q1

What the manager wrote

LeMaitre Vascular, Inc. (LMAT) continues to demonstrate its ability to convert steady procedure-driven demand into significant profit growth. The company achieved a 47% increase in operating income on mid-teens revenue growth, showcasing strong operating leverage. Investors have responded positively to LMAT's consistent execution and high visibility in a volatile market, reinforcing our belief in its durable growth characteristics and potential for long-term value creation.

Browse all fund letters →

Press Release

	Subject	Date
No Press Release

Articles on LeMaitre Vascular Inc

No articles.

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.